NCT00880581 A Phase 2 Intratumoral Injection PF-3512676 Plus Local Radiation in Low-Grade B-Cell Lymphomas Status COMPLETED Phase PHASE2
NCT00880009 Study Evaluating Bosutinib-Letrozole Combination Versus Letrozole Alone In Post Menopausal Women With Breast Cancer Status TERMINATED Phase PHASE2
NCT00879983 An Open Label, Randomized, Crossover Study To Estimate The Pharmacokinetics And Evaluate The Safety Following A Single Dose Of Azithromycin 2g Extended-Release Powder For Oral Suspension With A 3-Day Dosing Regimen Of Azithromycin 500mg Tablet In Chinese Healthy Male Subjects Status COMPLETED Phase PHASE1
NCT00879814 Study Evaluating Safety And Tolerability Of Meningococcal B Rlp2086 Vaccine In Healthy Adults Status COMPLETED Phase PHASE1
NCT00879684 Safety And PK Study Of CVX-060 In Patients With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT00879554 A Safety And Pharmacokinetic Study With CVX-045 In Patients With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT00877539 A Study To Assess The Effect Of PF-03526299 On Lung Function Following An Allergen Challenge In Asthmatic Subjects Status COMPLETED Phase PHASE1
NCT00877045 Treatment Patterns in Gastrointestinal Stromal Tumors in the Community Oncology Setting Status COMPLETED Phase N/A
NCT00877032 Safety And Tolerability Study Of RN6G In Patients With Dry, Age-Related Macular Degeneration Status COMPLETED Phase PHASE1
NCT00875628 A Study To Investigate Safety, Tolerability, And Pharmacokinetics Of PF-00868554 In Japanese Healthy Adult Volunteers Status TERMINATED Phase PHASE1
NCT00875030 A Study Comparing Blood Levels After Single-Dose Administration Of Artesunate Sachets (Pfizer) Versus Single-Dose Administration Of Arsuamoon® Tablets (Guilin-China) In Healthy Subjects Status COMPLETED Phase PHASE4
NCT00871494 Study Of Azithromycin Intravenous Formulation Against Pelvic Inflammatory Disease (PID) In Japan Status COMPLETED Phase PHASE3
NCT00869011 Exercise for Patients With Renal Cell Cancer Receiving Sunitinib Status UNKNOWN Phase PHASE3
NCT00868608 Study Evaluating Inotuzumab Ozogamicin (CMC-544) In Indolent Non-Hodgkins Lymphoma Status COMPLETED Phase PHASE2
NCT00868530 Study Evaluating On-Demand Treatment Of Xyntha In Chinese Subjects Status COMPLETED Phase PHASE3